. 2022 May 26;5(5):e2214153. doi: 10.1001/jamanetworkopen.2022.14153

Table 3. Annual National Attributable 30-Day Expenditures of Inappropriate Antibiotic Prescriptions Among the US Commercially Insured Population, Aged 6 Months to 17 Years^a.

Index diagnoses	Attributable expenditures, 2018 US $
Index diagnoses	Inpatient medical	Emergency department	Outpatient medical	Outpatient pharmacy	Total
Bacterial infections (primary analysis)
Suppurative OM	1 235 313	777 904	7 846 200	15 441 487	25 300 317
Pharyngitis	−750 188	2 564 653	6 706 388	12 752 577	21 271 338
Sinusitis	−503 873	277 773	407 416	6 899 358	7 078 513
Viral infections (secondary analysis)
Influenza	−98 806	−53 888	1 132 300	615 754	1 594 541
Viral URI	5 430 897	439 555	8 243 074	5 023 360	19 132 099
Bronchiolitis	−334 451	48 984	88 877	159 028	−37 871
Bronchitis	1 059 296	−2 593 873	−4 624 124	2 988 452	−3 173 797
Non-suppurative OM	−16 270	−962 935	−17 980 659	3 569 023	−15 395 644

Abbreviations: OM, otitis media; URI, upper respiratory infection.

^{^a}

Bronchiolitis cohort was restricted to ages 6 months to 3 years; bronchitis cohort was restricted to ages 5 to 17 years. The 95% confidence intervals are presented in eTable 16 in the Supplement.

Table 3. Annual National Attributable 30-Day Expenditures of Inappropriate Antibiotic Prescriptions Among the US Commercially Insured Population, Aged 6 Months to 17 Yearsa.

Table 3. Annual National Attributable 30-Day Expenditures of Inappropriate Antibiotic Prescriptions Among the US Commercially Insured Population, Aged 6 Months to 17 Years^a.